BriaCell Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCTX and other ETFs, options, and stocks.About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer.
BCTX Key Statistics
Stock Snapshot
The current BriaCell Therapeutics(BCTX) stock price is $4.49, with a market capitalization of 8.48M. The stock trades at a price-to-earnings (P/E) ratio of -0.09.
On 2026-01-16, BriaCell Therapeutics(BCTX) stock traded between a low of $4.46 and a high of $4.80. Shares are currently priced at $4.49, which is +0.7% above the low and -6.5% below the high.
BriaCell Therapeutics(BCTX) shares are trading with a volume of 1.19M, against a daily average of 1.47M.
During the past year, BriaCell Therapeutics(BCTX) stock moved between $4.46 at its lowest and $98.20 at its peak.
During the past year, BriaCell Therapeutics(BCTX) stock moved between $4.46 at its lowest and $98.20 at its peak.
BCTX News
(RTTNews) - BriaCell Therapeutics Corp. (BCTX) shares were trading at $10.61, up 39.06% or $2.98 higher, following news of a sustained complete resolution of a...
